Fortis Hospitals Mumbai Launches Citywide Campaign for Brain Health Awareness on World Brain Day
Fortis Mumbais Helmet Pehna Kya sqad all set to engage Mumbaikars on World Brain Day 2025
Volunteers wearing helmets attracted attention and struck up conversations everywhere from local trains and flower markets to office parks and roadside food stands, leading Mumbaikars to wonder, 'Why are they wearing the helmet here'The answer To emphasize a crucial point: your brain should be protected every day, not only in the event of an accident. Fortis Hospitals Mumbai questioned common belief that brain safety is solely related to accident-related trauma by introducing a symbol of physical protection (the helmet) in routine, low or no-risk situations. Instead, the campaign reframed helmets as a symbol of routine checkups, mental wellness, early detection, and lifestyle modification. The initiative aims to remind people that brain health is a daily priority rather than an emergency, this innovative activation not only attracted Mumbaikars attention but also struck the relevant conversations.
This initiative couldn't be timed better. Across India, neurological disorders are becoming an everyday reality for more and more families. Over the past three decades, cases of conditions like Stroke, Epilepsy, Migraine, and Dementia have more than doubled. Today, these account for almost 10% of the nation's overall disease burden; Stroke alone took the lives of nearly 7 lakh people in 2019. What's alarming is that stressors we live with daily: high blood pressure, poor diet choices, rising pollution levels, and chronic mental strain are the triggers. A comprehensive study led by the India State-Level Disease Burden Initiative-supported by ICMR, PHFI, IHME, and the Ministry of Health-highlighted these trends and published the findings in The Lancet Global Health. It is wake-up call, our brain health is far more fragile than we realise. That's what makes the Fortis Mumbai campaign so meaningful. By turning helmet into a powerful symbol, and carries a message that's hard to miss: protecting your brain is not just about reacting to emergencies; it's about living more mindfully, every single day.
Talking about the initiative, Dr S Narayani, Business Head – Fortis Hospitals, Maharashtra, said, 'At Fortis, our mission goes beyond treating illness, we aim to prevent it through education and awareness. The helmet is a powerful choice for the campaign as it reminds us that just as we protect our head from injury on the roads, we must also protect our brain through awareness, timely action, and healthy choices. For us preventative healthcare is the foundation of a healthy society and through this campaign, we hope to engage the community, and empower them to take proactive steps towards better brain health.'
As part of World Brain Day, Fortis Hospitals in Mumbai brought brain health awareness to the forefront with a unique, people-first approach. At all four units-Mulund, Kalyan, Vashi, and Mahim-Patient Care Services staff wore helmets within hospital premises, sparking heartfelt conversations with patients and their families about the importance of brain health. Community sessions hosted at open spaces helped Neurologists share insights on recognizing early warning signs, and stressed the value of timely care. The initiative extended to notable locations across Mumbai, as reactions and real-time moments were shared across Fortis Mumbai's social media pages, helping the message of brain health reach the community at large.
'When it comes to brain health, lifestyle plays a very important role and should not be overlooked. One particular acronym that tell my patients to lookout for is termed SHAAADOWSSS, which stands for Smoking, Hypertension, Age over 60 years, Alcohol Abuse, Atrial fibrillation, Diabetes, Obesity, Wellspring (family history), Stress, Sedentary Lifestyle and Sleep Disorders. True to its name, these conditions follow you around like a shadow and if left unmanaged they significantly increase your risk of developing issues like Stroke. The good news is simple, conscious changes in your daily routine can drastically lower that risk and protect your brain for the long run,' said Dr Ashok Hande, Director – NeuroSurgery, Fortis Hiranandani Hospital, Vashi, while talking about the role lifestyle awareness plays in brain health preservation.
Dr Sreelakshmi N. Consultant-Neurology, S.L. Raheja Hospital, Mahim, said, 'Everything you experience flows from the brain. Yet, your brain remains the body's most sensitive organs. Issues like Stroke can appear suddenly, while conditions such as Dementia may develop gradually and quietly. That's why paying attention to even subtle changes matters. Don't ignore the signs your body may be giving you. Acting early can change outcomes.'
Highlighting the role family history, Dr Gurneet Singh Sawhney, Director-Stereotaxy and Functional Neurosciences, Fortis Hospital, Mulund said, 'Family history plays a crucial role when managing disease burden. If someone in the patient's family has had ailments like Dementia, Stroke etc. then one's chances of developing neurological complications may be higher. That makes it even more critical to be aware of the warning signs, get regular health check-ups, and adopt a healthy lifestyle to reduce your risk.'
DrRushabh Chheda, Consultant, Neurosurgery and Stroke Intervention Specialist, Fortis Hospital Kalyan, said, 'Brain health is too important to take chances with. Any warning sign you observe should be taken as a medical emergency, not be considered a wait-and-watch situation. There is a common saying in Neurology which says – time is brain – thus the quicker you act, the more brain function can be saved and every minute counts when it comes to protecting your brain and your life, so act fast to preserve what matters most.'
The message is clear: it's time for Mumbai to act decisively with stronger strategies for prevention, better awareness, and more accessible neurological care-before this silent epidemic grows louder.
About Fortis Healthcare
Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 27 healthcare facilities, ~4,750 operational beds (including O&M facilities), and over 400 diagnostics centers (including JVs). The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with a global major and parent company – IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs over 23,000 people (including Agilus Diagnostics Limited) who share its vision of becoming the world's most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
6 hours ago
- News18
ICMR study finds shortfall in radiotherapy utilisation across all cancer types
Agency: Last Updated: July 24, 2025, 21:30 IST Representational image (Image: News18) New Delhi, Jul 24 (PTI) A recent ICMR study has highlighted a substantial shortfall in radiotherapy utilisation across all cancer types and underscored the need for interventions to meet the gap in machines required for equitable cancer care. Published in the BMC Cancer journal, the study stated that 28.5 per cent of cancer patients receive radiotherapy, which is lower than the estimated optimal rate of 58.4 per cent. Breast, head and neck, lung and cervical cancer account for 60 per cent of India's radiotherapy needs, it said. Data from the Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used by the researchers of ICMR-National Centre for Disease Informatics and Research, Bengaluru, for conducting the study. Epidemiological data on stage, subsite and histology from the National Cancer Registry Programme were used to assess the optimal utilisation proportion for India. A sensitivity analysis was carried out. Similarly, the optimal radiotherapy fraction has also been calculated. These measures have been used to estimate the existing radiotherapy utilisation gap by comparing with the current radiotherapy utilisation from the cancer registry as well as to estimate the optimal radiotherapy machines required for the country. 'This study provides a comprehensive assessment of radiotherapy demand and existing gaps in radiotherapy utilisation and in the number of machines in India based on an epidemiological analysis of the cancer burden from the National Cancer Registry Programme. Our analysis shows that approximately 58 per cent of all cancer cases in India should ideally receive radiotherapy based on clinical indications. 'However, the current radiotherapy utilisation in India is only 28.5 per cent, which is less than half of the required level," the researchers said. The study also recommended that India would require 1,585 to 2,545 machines, which may increase to a range of 2,016 to 2,291 external beam radiotherapy machines if the assumptions from previous benchmark studies are followed. The burden of four cancer sites — breast, head and neck, lung and cervical cancer — constitutes around 60 per cent of the total radiotherapy requirement for cancer care in India, the study said. This points towards an increasing demand for radiotherapy in the coming years as there is expected to be a 70-100 per cent increase in breast, head and neck and lung cancer in low and middle income countries (LMIC). Radiotherapy utilisation of most cancer sites is lower compared to optimal radiotherapy utilisation. Among the major indicated cancer sites, the deficit is more prominent in lymphoma and lung cancer (relative deficit of more than 70 per cent), followed by prostate, breast and oesophagus, it said. The study mentioned that India accounts for 7 per cent of global cancer incidence, ranking third after China and the USA. By the end of 2025, the incidence of cancer in India is projected to reach 1.57 million cases, posing a significant public health challenge. As the fifth leading cause of death in the country, cancer demands urgent attention to improve prevention, diagnosis and treatment, it said. Radiotherapy, a cornerstone of cancer treatment, plays a crucial role in controlling tumour growth, reducing tumour size pre-surgery, and alleviating pain in advanced stages. However, its availability in low and middle-income countries like India remains insufficient due to high setup and operational costs, creating a significant gap between demand and resources. The World Health Organization (WHO) recommends a minimum of one radiotherapy machine (external radiotherapy machine) per million population, with an optimal target of four per million, the study stated. For India's projected population of 1.45 billion in 2025, this translates to a need for a minimum of 1,450 machines. Yet, only 794 megavoltage (MV) machines are currently available. The shortfall is about 45 per cent from the minimal required standard, the study said. The study highlighted that in India, greater investment is needed to expand radiotherapy facilities to meet the growing demands of cancer patients. 'Aside from increasing the number of equipment, addressing the inequitable distribution of radiotherapy services is also crucial. To align with the country's cancer burden and ongoing cancer control efforts, India must meet evidence-based targets for radiotherapy machine availability. 'As a part of this, India is also ramping up efforts to develop and deploy affordable indigenous radiotherapy machines to improve access and reduce dependence on costly imports," the study stated. Furthermore, a detailed situational study of radiation equipment deployment with its features and complexity, utilisation and throughput is required for informed planning and policymaking. Cancer screening and early detection programmes can facilitate the diagnosis of cancers at earlier stages. This could reduce the required quantum of radiotherapy shortly and thus, improve the overall survival of patients, the study said. The cancer registry data informs the policy-makers to identify gaps in radiotherapy access, assess resource needs and guide decisions to ensure equitable and effective cancer care delivery. Swipe Left For Next Video View all Optimal radiotherapy utilisation (RTU) calculated for India was higher than optimal radiotherapy utilisation estimation done for developed countries like 48·3 per cent for Australia and 51 per cent for European countries, the study said. The optimal RTU calculation for middle income countries also has an average optimal radiotherapy utilisation value of 52 per cent ranging from 47 to 56 per cent. PTI PLB KSS KSS (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments News agency-feeds ICMR study finds shortfall in radiotherapy utilisation across all cancer types Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
10 hours ago
- News18
ICMR recommends interventions to meet gap in machines needed for cancer care
New Delhi, Jul 24 (PTI) A recent ICMR study has highlighted a substantial shortfall in radiotherapy utilisation across all cancer types and underscored the need for interventions to meet the gap in machines required for equitable cancer care. Published in the BMC Cancer journal, the study stated that 28.5 per cent of cancer patients receive radiotherapy, which is lower than the estimated optimal rate of 58.4 per cent. Breast, head and neck, lung and cervical cancer account for 60 per cent of India's radiotherapy needs, it said. Data from the Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used by the researchers of ICMR-National Centre for Disease Informatics and Research, Bengaluru, for conducting the study. Epidemiological data on stage, subsite and histology from the National Cancer Registry Programme were used to assess the optimal utilisation proportion for India. A sensitivity analysis was carried out. Similarly, the optimal radiotherapy fraction has also been calculated. These measures have been used to estimate the existing radiotherapy utilisation gap by comparing with the current radiotherapy utilisation from the cancer registry as well as to estimate the optimal radiotherapy machines required for the country. 'This study provides a comprehensive assessment of radiotherapy demand and existing gaps in radiotherapy utilisation and in the number of machines in India based on an epidemiological analysis of the cancer burden from the National Cancer Registry Programme. Our analysis shows that approximately 58 per cent of all cancer cases in India should ideally receive radiotherapy based on clinical indications. 'However, the current radiotherapy utilisation in India is only 28.5 per cent, which is less than half of the required level," the researchers said. The study also recommended that India would require 1,585 to 2,545 machines, which may increase to a range of 2,016 to 2,291 external beam radiotherapy machines if the assumptions from previous benchmark studies are followed. The burden of four cancer sites — breast, head and neck, lung and cervical cancer — constitutes around 60 per cent of the total radiotherapy requirement for cancer care in India, the study said. This points towards an increasing demand for radiotherapy in the coming years as there is expected to be a 70-100 per cent increase in breast, head and neck and lung cancer in low and middle income countries (LMIC). Radiotherapy utilisation of most cancer sites is lower compared to optimal radiotherapy utilisation. Among the major indicated cancer sites, the deficit is more prominent in lymphoma and lung cancer (relative deficit of more than 70 per cent), followed by prostate, breast and oesophagus, it said. The study mentioned that India accounts for 7 per cent of global cancer incidence, ranking third after China and the USA. By the end of 2025, the incidence of cancer in India is projected to reach 1.57 million cases, posing a significant public health challenge. As the fifth leading cause of death in the country, cancer demands urgent attention to improve prevention, diagnosis and treatment, it said. Radiotherapy, a cornerstone of cancer treatment, plays a crucial role in controlling tumour growth, reducing tumour size pre-surgery, and alleviating pain in advanced stages. However, its availability in low and middle-income countries like India remains insufficient due to high setup and operational costs, creating a significant gap between demand and resources. The World Health Organization (WHO) recommends a minimum of one radiotherapy machine (external radiotherapy machine) per million population, with an optimal target of four per million, the study stated. For India's projected population of 1.45 billion in 2025, this translates to a need for a minimum of 1,450 machines. Yet, only 794 megavoltage (MV) machines are currently available. The shortfall is about 45 per cent from the minimal required standard, the study said. The study highlighted that in India, greater investment is needed to expand radiotherapy facilities to meet the growing demands of cancer patients. 'Aside from increasing the number of equipment, addressing the inequitable distribution of radiotherapy services is also crucial. To align with the country's cancer burden and ongoing cancer control efforts, India must meet evidence-based targets for radiotherapy machine availability. 'As a part of this, India is also ramping up efforts to develop and deploy affordable indigenous radiotherapy machines to improve access and reduce dependence on costly imports," the study stated. top videos View all Furthermore, a detailed situational study of radiation equipment deployment with its features and complexity, utilisation and throughput is required for informed planning and policymaking. Cancer screening and early detection programmes can facilitate the diagnosis of cancers at earlier stages. This could reduce the required quantum of radiotherapy shortly and thus, improve the overall survival of patients, the study said. The cancer registry data informs the policy-makers to identify gaps in radiotherapy access, assess resource needs and guide decisions to ensure equitable and effective cancer care delivery. PTI PLB KSS KSS view comments First Published: July 24, 2025, 18:15 IST News agency-feeds ICMR recommends interventions to meet gap in machines needed for cancer care Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
India Today
12 hours ago
- India Today
Genes and the brain: The role of testing in early diagnosis
We are all aware that the brain is one of the most vital parts of our bodies. Despite this, it remains largely overlooked in broader conversations on physical health. In India, concerns around brain health are steadily increasing, with nearly 15 million people affected by neurological disorders such as Alzheimer's, stroke, and epilepsy, according to the Indian Council of Medical Research (ICMR).advertisementIndia Today spoke with Dr Thenral S Geetha, Principal Scientist at MedGenome, to understand how genetics is transforming the way we approach brain health and what this could mean for individuals and families navigating complex neurological ROLE OF GENES IN BRAIN HEALTHAnswers to our brain's health often lie in our genes. From a seizure in a child to an adult's struggle with memory, understanding our genetic makeup is increasingly helping us uncover the true origins of various brain conditions across all ages. It is essential to acknowledge this crucial relationship between genetics and brain health, addressing the factors that influence our predisposition to neurological diseases, cognitive function, and mental the right tests, doctors and families can now get a clearer picture sooner, leading to more accurate diagnoses, more effective treatments, and, importantly, peace of mind. These tests aren't just about figuring out "why"—they're also about discovering "what's next," whether that involves treatment, family planning, or long-term BRAIN PROBLEMS ARE LINKED TO YOUR GENESWhile some brain conditions are inherited, others arise from new variations in genes that weren't passed down but still impact how the condition develops. Doctors may consider a genetic cause when symptoms begin early in life, when multiple family members are affected, or when the condition shows unusual example, epilepsy is more likely to have a genetic basis if seizures begin in babies or young children, especially when no other cause is clear. Identifying the gene involved can help clinicians choose the right treatment early. In children, developmental delays, learning challenges, or autistic traits—particularly when combined with other physical anomalies—can also have a genetic conditions, however, emerge later in life. Huntington's disease, for example, typically begins between the ages of 30 and 50 and affects movement, cognition, and behaviour. It results from a mutation in the HTT gene. Even Alzheimer's disease, which is usually linked with ageing, can have a genetic link, especially in early-onset cases or when there's a strong family history. Similarly, Parkinson's disease may have a genetic influence even when there is no clear family history, with specific gene mutations interacting with environmental risk GENETIC TESTING CAN DO FOR YOUIf conventional scans and exams don't explain a brain condition, doctors may recommend genetic testing to uncover the cause. Today, several testing methods are available in India, including:advertisementGene panels: Targeted testing of genes known to be linked to specific conditions like early-onset epilepsy or Parkinson'sWhole-exome sequencing: Scans all known genes for changesChromosomal microarray: Detects missing or duplicated DNA segments, often used for developmental disorders in childrenThese tests are typically done through blood or, in some cases, saliva. The results can confirm diagnoses, narrow down treatment options, or help identify future risks. Importantly, they offer families clarity—and with that, the power to make informed counselling is a critical part of the process. Genetic counsellors help families understand inheritance patterns, how genes work, the types of tests available, and possible management or treatment routes. They also provide emotional support to help navigate the psychological impact of genetic TESTING EARLY MATTERSEarly genetic testing not only shortens the diagnostic journey but also reduces long-term care costs. For children, early diagnosis enables tailored support and helps families prepare for the future. In adults, knowing the genetic cause supports better care, lifestyle changes, and treatment planning. Genetic insights can also guide couples in pregnancy planning, especially when a family history of neurological issues tests deepen our understanding of brain conditions, opening doors to personalised medicine and more precise care.- Ends
